Cell lines "Points to Consider"
Executive Summary
FDA requests comments on revised draft of the "Points to Consider in the Characterization of Cell Lines Used to Produce Biologicals" in August 12 Federal Register notice. The revised draft supersedes the 1987 "Points to Consider" on cell lines.